@MondayNightIBD: Identifying the Factors that Impact Success in Your Practice

CMEO Webcast

Premiere Date: Monday, October 26, 2020

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. ABIM (MOC)
  5. Other


All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Tuesday, October 26, 2021

Begin Activity Now

Faculty


Aline Charabaty, MD, AGAF Aline Charabaty, MD, AGAF 
Clinical Director of Gastroenterology
Director of Inflammatory Bowel Disease Center
Sibley Memorial Hospital
Assistant Professor of Medicine
Johns Hopkins School of Medicine
Washington, DC

Christina Ha, MD, FACG, AGAF Christina Ha, MD, FACG, AGAF 
Associate Professor of Medicine
The F. Widjaja Foundation Inflammatory Bowel Immunology Research Institute at Cedars-Sinai
Los Angeles, CA

Statement of Need

@MondayNightIBD brings social media and clinical practice influencers in gastroenterology together in a weekly online conversation that has become an international platform, moving the field of gastroenterology forward. It crowdsources the knowledge and experience of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD.

In this webcast, CME Outfitters and @MondayNightIBD come together to bring you a panel of experts who will tailor a series of patient cases. These cases will focus on the application of cutting-edge data for novel therapies, identifying appropriate treatment strategies for special populations such as young patients and racial/ethnic minorities, and developing patient communication strategies, with the aim of achieving optimal patient outcomes.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Apply efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
  • Identify appropriate treatment strategies for special populations with IBD such as young patients and racial/ethnic minorities.
  • Develop strategies such as disease monitoring, shared decision-making (SDM), and patient education in order to achieve optimal patient outcomes.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Explain efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
  • Identify appropriate treatment strategies for special populations with IBD such as young patients and racial/ethnic minorities.
  • Identify strategies such as disease monitoring, SDM, and patient education in order to achieve optimal patient outcomes.

Financial Support

Supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Target Audience

Gastroenterologists, primary care physicians, PAs, nurse practitioners, nurses, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs). Universal Activity Number: Enduring: 0376-0000-20-154-H01-P

Type: Knowledge-based

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats:
Enduring material

Royal College MOC Credit:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.

Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Charabaty reports that she serves on the advisory committee for Janssen Pharmaceuticals, Inc. She is a consultant for AbbVie Inc.; Janssen Pharmaceuticals, Inc.; and Pfizer Inc.

Dr. Ha reports that she receives research support from Pfizer Inc. She serves on the advisory committee for AbbVie Inc.; Genentech Inc.; InDex Pharmaceuticals; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Olga Askinazi, PhD (planning committee) has no disclosures to report.

Susan Perry (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty has been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

MMV-108-102620-90